Honasa drops 58% stake buy in Fluence Pharma
Honasa drops 58% stake buy in Fluence Pharma — Honasa Consumer has abandoned its proposed acquisition of a 58% stake in Fluence Pharma due to strategic reassessment. The move may impact near-term expansion plans for both firms. Fluence Pharma remains independent with no immediate change in ownership.
📊 STOCKS: HONASA, FLUENCEPHAR | 🏢 SECTOR: Corporate | #MEDIUMIMPACT #M&A
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.